MESO CIK: 1345099

Mesoblast Ltd Sponsored ADR

  • Australia
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−65.8
FY23:
−63.3
FY24:
−48.5
FY25:
−50.0
Change from FY21 to FY25
millions USD
FY21:
−1.65
FY22:
−0.23
FY23:
−0.19
FY24:
−0.10
FY25:
0.12
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
−9.87
FY23:
74.5
FY24:
40.3
FY25:
147
millions USD
FY21:
6.14
FY22:
−75.9
FY23:
11.0
FY24:
−8.30
FY25:
97.5
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−63.5
FY24:
−48.7
FY25:
−50.6

All amounts in millions USD Data source:SEC EDGAR